Cover Image


View/Hide Left Panel

29. Day, R., Smith, J.R., and Klingman, W.O. Tests of function of vegetative nervous system in acrodynia. Am. J. Dis. Child. 57: 269–277. 1939.

30. Hubble, D. Phaeochromocytoma in children. Arch. Dis. Childhood 26:340–350, 1951.

31. Vulliamy, G.D. Vasomotor disturbance in pink disease. Lancet 2:1248–1251, 1952.

32. Farquhar, J.W., Crawford, T.B.B., and Law, W. Urinary sympathin excretion of normal infants and of infants with pink disease. Brit. M. J. 2:276–281, 1956.

33. Cheek, D.B., and Wu, F. Effect of calomel on plasma epinephrine in rat and relationship to mechanisms in pink disease. Arch. Dis. Childhood 34:502–504, 1959.

34. Cheek, D.B., Bondy, R.K., and Johnson, L.R. Effect of mercurous chloride (calomel) and epinephrine (sympathetic stimulation) on rats: importance of findings to mechanisms in infantile acrodynia (pink disease). Pediatrics 23:302–313, 1959.

35. Peterson, J.C., and Laughmiller, R. Acrodynia, treatment with adrenolytic drugs. Acta paediat. 43(Supp. 100):517–525, 1954.

36. Bower, B.D. Pink disease: autonomic disorder and its treatment with ganglion-blocking agents. Quart. J. Med. 23:215–230, 1954.

37. Ritzel, G., Berger, H., and Roulet, D.L.A. Increased catecholamine excretion in case of acrodynia: (pink disease). Ann. Paediat. 198:81–88, 1962.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement